PIRAMAL CAPITAL & HOUSING FINANCE

OVERVIEW
 Piramal Enterprises Ltd is one of the largest pharmaceutical companies in India.The company
operates two divisions namely healthcare solutions and pharma solutions.The products and services
offered by the company includes Pharma Solutions- This division is engaged in manufacturing of API
and formulations in nine therapeutic areas.
 The company operates one of the leading custom manufacturing businesses in the world, due to
this PHL offers a full lifecycle partnership to small/virtual and big pharma. They provide services
such as clinical phase APIs, clinical phase formulations and commercial APIs. They also offer
packaging solutions.Healthcare solutions- Under this, PHL has developed multi-ingredient
formulations and single-ingredients products.
Board of directors
Piramal Enterprises Limited (PEL) is one of the large companies in India, with a presence in Financial
Services and Pharmaceuticals. PEL’s consolidated revenues were US$1.7 Billion in FY 2021, with
~37% of revenues generated from outside India.

Total asset is Rs 77,119cr. as on 31 Mar 2021

22% revenue of CAGR for 33 years

24% Annualised shareholder returns over last 33 years

FY 2021 revenues at `12,809 Crore were broadly stable YoY

Revenue for FY21 were Rs 7,033cr. Down, 8% YOY due to reduction in whole sale.

Revenue for FY21 were Rs 5776cr, up 7% YOY by strong performance in CDMO.

Normalized Net Profit of `2,627 Crore for FY 2021 was in line with `2,615 Crore in FY 2020

Sold or exited non-core businesses / investments (such as DRG and stake in Shriram
Transport)

Brought Pharma businesses together under Piramal Pharma Limited

Strengthened the balance sheets of both businesses to enable them to stand independently in
future

Created separate Board and Management teams for both businesses

Income statement
Over the last 5 years, revenue has grown at a yearly rate of 14.69%, whereas industry
average is 11.33%

Over the last 5 years, market share increased from 11.85% to 13.6%
Balance sheet
• Over the last 5 years, debt to equity ratio has been 165.31%, whereas industry average is
349.61%
• Over the last 5 years, current ratio has been 71.59%, industry average is 51.34%

• In last 6 months, promoter holding in the

company has decreased by 2.54%

• Pledged promoter holdings is insignificant

• In last 3 months, mutual fund holding of the

company has almost stayed constant

• In last 3 months, foreign institutional holding of

the company has increased by 4.20%

Lower pledged promoter holdings is considered better